Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03491293 · ClinicalTrials.gov registry record · NA
Piloting Visual Chat in Internet Obesity Treatment
A NA study, sponsored by University of Vermont.
- Completed
- Registry status
- NA
- Development phase
- 32
- Enrollment target
NCT03491293: Completed NA study, sponsored by University of Vermont.
NCT03491293 is a NA study that has completed, run by University of Vermont. The registered enrollment target is 32 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03491293, a NA study, has completed, sponsored by University of Vermont.
- COMPLETED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
Study Summary
CHAT is an internet-based weight loss research program designed for women with overweight or obesity who want to lose weight through dietary change and increased physical activity. Participants will be randomized into a group-based online program who meet via a text chat or a video chat.
Primary Outcome
The investigators will assess weight change differences between subjects randomized to receive an internet program alone with text chat vs. an internet program with visual chat and bodytrace smart scales. Weight will be assessed at baseline, 2 months after intervention begins, and at the end of intervention using a calibrated digital scale (Tanita, WB800S) with subjects in street clothes, without shoes.
Interventions
- BEHAVIORAL Behavioral Weight Loss + Text
- BEHAVIORAL Behavioral Weight Loss + Video
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2018-03-06 |
| Est. Completion | 2018-11-30 |
| Phase | NA |
What the finished NCT03491293 record still lists
NCT03491293 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Behavioral Weight Loss + Text is the first listed.
NCT03491293 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03491293 about?
NCT03491293 is a clinical study titled "Piloting Visual Chat in Internet Obesity Treatment". CHAT is an internet-based weight loss research program designed for women with overweight or obesity who want to lose weight through dietary change and increased physical activity. Participants will be randomized into a group-based online program who meet via a text chat or a video chat.
What is the current status of trial NCT03491293?
This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2018-03-06. Estimated completion is 2018-11-30.
What interventions are being tested in trial NCT03491293?
The interventions under investigation include: Behavioral Weight Loss + Text (BEHAVIORAL), Behavioral Weight Loss + Video (BEHAVIORAL).
Who is sponsoring clinical trial NCT03491293?
This trial is sponsored by University of Vermont, which has 162 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03491293's enrollment target sits among peer trials
32 1578th of 2000 higher than 409 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI